Download Files:
Migoprotafib
SKU
HY-144903-10 mg
Category Reference compound
Tags Cancer, Metabolic Enzyme/Protease;Protein Tyrosine Kinase/RTK, Phosphatase;SHP2
$625 – $4,500
Products Details
Product Description
– Migoprotafib (GDC-1971) (compound 199) is a SHP2 inhibitor[1].
Web ID
– HY-144903
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C25H26N8O
References
– [1]Alexander M, et al. Shp2 phosphatase inhibitors and methods of use thereof. Patent WO2019183367A1.
CAS Number
– 2377352-49-1
Molecular Weight
– 454.53
Compound Purity
– 98.06
SMILES
– N[C@H]1C2(CCN(C3=CN=C(C(N4C5=CC=CN=C5CCC4)=NN6)C6=N3)CC2)OC7=CC=CC=C71
Clinical Information
– Phase 1
Research Area
– Cancer
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Phosphatase;SHP2
Pathway
– Metabolic Enzyme/Protease;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.